Novartis Ag ADR (NVS)
112.63 +0.49 (+0.44%) 04/28/25 [NYSE]
104.11 x 100 113.06 x 500
Realtime by (Cboe BZX)
104.11 x 100 113.06 x 500
Realtime 112.85 +0.22 (+0.20%) 18:49 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NVS | NVO | MRK | ||
| Company | Novartis Ag ADR | Novo Nordisk A/S ADR | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 112.33 | 62.19 | 83.00 | ||
| High | 113.44 | 63.25 | 83.68 | ||
| Low | 112.17 | 61.97 | 82.40 | ||
| Last | 112.63 | 62.62 | 83.19 | ||
| Change | +0.49 | +0.54 | +0.45 | ||
| % Change | +0.44% | +0.87% | +0.54% | ||
| Volume | 2,477,000 | 6,280,300 | 14,240,900 | ||
| 20-Day Average Volume | 2,588,845 | 10,306,450 | 17,683,449 | ||
| Previous Close | 112.14 | 62.08 | 82.74 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.87 | 63.50 | 81.17 | ||
| 20-Day Raw Stochastic | 89.18% | 43.23% | 50.65% | ||
| 20-Day Relative Strength | 56.71% | 39.88% | 46.65% | ||
| Weighted Alpha | +13.91 | -55.23 | -36.08 | ||
| Today's Opinion | 48% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 48% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.89% since 04/21/25 | +7.35% since 04/21/25 | +6.86% since 04/21/25 | ||
| Low | 109.51 on 04/23/25 | 58.92 on 04/22/25 | 76.03 on 04/24/25 | ||
| High | 113.44 on 04/28/25 | 63.25 on 04/28/25 | 83.68 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +0.05% since 03/28/25 | -9.64% since 03/28/25 | -6.77% since 03/28/25 | ||
| Low | 97.71 on 04/09/25 | 57.00 on 04/21/25 | 75.93 on 04/16/25 | ||
| High | 114.44 on 04/03/25 | 70.00 on 04/01/25 | 90.26 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +10.60% since 01/28/25 | -26.49% since 01/28/25 | -14.63% since 01/28/25 | ||
| Low | 97.71 on 04/09/25 | 57.00 on 04/21/25 | 75.93 on 04/16/25 | ||
| High | 116.91 on 03/10/25 | 93.80 on 02/25/25 | 100.15 on 02/03/25 | ||
| 6-Month | |||||
| %Chg | -2.59% since 10/28/24 | -44.27% since 10/28/24 | -20.19% since 10/28/24 | ||
| Low | 96.06 on 12/20/24 | 57.00 on 04/21/25 | 75.93 on 04/16/25 | ||
| High | 116.91 on 03/10/25 | 113.76 on 10/30/24 | 105.11 on 10/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 223,599,872 | 280,695,136 | 205,447,712 | ||
| Shares Outstanding, K | 2,112,422 | 4,487,532 | 2,521,759 | ||
| Annual Sales | 51,722,000,000 | 42,108,430,000 | 64,168,000,000 | ||
| Annual Net Income | 11,941,000,000 | 14,643,260,000 | 17,117,000,000 | ||
| Last Quarter Sales | 13,558,000,000 | 12,261,320,000 | 15,624,000,000 | ||
| Last Quarter Net Income | 2,818,000,000 | 4,026,620,000 | 3,743,000,000 | ||
| 60-Month Beta | 0.56 | 0.61 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.98 on 01/31/25 | 0.91 on 02/05/25 | 2.22 on 04/24/25 | ||
| Latest Earnings Date | 04/29/25 | 05/07/25 | 04/24/25 | ||
| Most Recent Dividend | 2.596 on 03/12/25 | 0.819 on 03/31/25 | 0.810 on 03/17/25 | ||
| Next Ex-Dividends Date | 03/12/25 | 03/31/25 | 03/17/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 14.36 | 18.87 | 10.62 | ||